Condensed Consolidated Statements of Operations - USD ($) shares in Thousands, $ in Thousands	3 Months Ended				9 Months Ended
	Nov. 02, 2024		Oct. 28, 2023		Nov. 02, 2024		Oct. 28, 2023
Income Statement [Abstract]
Net sales	$ 596,328	[1]	$ 579,315	[2]	$ 1,579,113	[3]	$ 1,585,674	[4]
Cost of sales	311,072		300,890		831,937		828,921
Gross margin	285,256		278,425		747,176		756,753
Selling and administrative expenses	274,912		267,474		777,878		778,491
Goodwill impairment	0		0		0		28,453	[5]
Asset impairments and other, net	134	[6]	99	[6]	1,490	[7]	581	[8]
Operating income (loss)	10,210		10,852		(32,192)		(50,772)
Other components of net periodic benefit cost	86		148		281		388
Interest expense, net	1,213		2,207		3,448		6,241
Earnings (loss) from continuing operations before income taxes	8,911		8,497		(35,921)		(57,401)
Income tax expense (benefit)	27,759		1,908		17,144		(13,483)
Earnings (loss) from continuing operations	(18,848)		6,589		(53,065)		(43,918)
Loss from discontinued operations, net of tax	(84)		(50)		(206)		(98)
Net Earnings (Loss)	$ (18,932)		$ 6,539		$ (53,271)		$ (44,016)
Basic earnings (loss) per common share:
Continuing operations (in dollars per share)	$ (1.76)		$ 0.6		$ (4.88)		$ (3.87)
Discontinued operations (in dollars per share)	0		0		(0.02)		(0.01)
Net earnings (loss) (in dollars per share)	(1.76)		0.6		(4.9)		(3.88)
Diluted earnings (loss) per common share:
Continuing operations (in dollars per share)	(1.76)		0.6		(4.88)		(3.87)
Discontinued operations (in dollars per share)	0		0		(0.02)		(0.01)
Net earnings (loss) (in dollars per share)	$ (1.76)		$ 0.6		$ (4.9)		$ (3.88)
Weighted average shares outstanding:
Basic (in shares)	10,737		10,898		10,870		11,353
Diluted (in shares)	10,737		10,972		10,870		11,353

[1] Net sales in North America and in the U.K., which includes the ROI, accounted for 80% and 20%, respectively, of our net sales in the third quarter of Fiscal 2025

[2] Net sales in North America and in the U.K., which includes the ROI, accounted for 80% and 20%, respectively, of our net sales for the third quarter of Fiscal 2024.

[3] Net sales in North America and in the U.K., which includes the ROI, accounted for 79% and 21%, respectively, of our net sales in the first nine months of Fiscal 2025.

[4] Net sales in North America and in the U.K., which includes the ROI, accounted for 79% and 21%, respectively, of our net sales for the first nine months of Fiscal 2024.

[5] Goodwill impairment of $28.5 million is related to Genesco Brand Group.

[6] Asset impairments and other includes a $0.1 million charge for asset impairments in Journeys Group.

[7] Asset impairments and other includes a $0.5 million charge for asset impairments in Journeys Group and $1.0 million for severance.

[8] Asset impairments and other includes a $0.6 million charge for asset impairments in Journeys Group.